2,572 results on '"tat"'
Search Results
2. Cell-penetrating peptides TAT and 8R functionalize P22 virus-like particles to enhance tissue distribution and retention in vivo.
- Author
-
Shibo Su, Xuegang Shen, Xinqi Shi, Xin Li, Jin Chen, Wei Yang, Mingxia Sun, Yan-Dong Tang, Haiwei Wang, Shujie Wang, Xuehui Cai, Yu Lu, Tongqing An, Yongbo Yang, and Fandan Meng
- Subjects
CELL-penetrating peptides ,VIRUS-like particles ,CELLULAR recognition ,PROTEIN models ,NANOPARTICLES - Abstract
Virus-like particles (VLPs) are used as nanocontainers for targeted drug, protein, and vaccine delivery. The phage P22 VLP is an ideal macromolecule delivery vehicle, as it has a large exterior surface area, which facilitates multivalent genetic and chemical modifications for cell recognition and penetration. Arginine-rich cell-penetrating peptides (CPPs) can increase cargo transport efficiency in vivo. However, studies on the tissue distribution and retention of P22 VLPs mediated by TAT and 8R are lacking. This study aimed to analyze the TAT and 8R effects on the P22 VLPs transport efficiency and tissue distribution both in vitro and in vivo. We used a prokaryotic system to prepare P22 VLP self-assembled particles and expressed TAT-or 8R-conjugated mCherry on the VLP capsid protein as model cargoes and revealed that the level of P22 VLP-mCherry penetrating the cell membrane was low. However, both TAT and 8R significantly promoted the cellular uptake efficiency of P22 VLPs in vitro, as well as enhanced the tissue accumulation and retention of P22 VLPs in vivo. At 24 h postinjection, TAT enhanced the tissue distribution and retention in the lung, whereas 8R could be better accumulation in brain. Thus, TAT was superior in terms of cellular uptake and tissue accumulation in the P22 VLPs delivery system. Understanding CPP biocompatibility and tissue retention will expand their potential applications in macromolecular cargo delivery. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Structural and Functional Dysregulation of the Brain Endothelium in HIV Infection and Substance Abuse.
- Author
-
Annadurai, Narendran and Kanmogne, Georgette D.
- Subjects
- *
AIDS , *HIV infections , *HIV-positive persons , *NEUROBEHAVIORAL disorders , *VIRAL proteins - Abstract
Blood–brain barrier (BBB) injury and dysfunction following infection with the human immunodeficiency virus (HIV) enables viral entry into the brain, infection of resident brain cells, neuronal injury and subsequent neurodegeneration leading to HIV-associated neurocognitive disorders (HAND). Although combination antiretroviral therapy has significantly reduced the incidence and prevalence of acquired immunodeficiency syndrome and increased the life expectancy of people living with HIV, the prevalence of HAND remains high. With aging of people living with HIV associated with increased comorbidities, the prevalence of HIV-related central nervous system (CNS) complications is expected to remain high. Considering the principal role of the brain endothelium in HIV infection of the CNS and HAND, the purpose of this manuscript is to review the current literature on the pathobiology of the brain endothelium structural and functional dysregulation in HIV infection, including in the presence of HIV-1 and viral proteins (gp120, Tat, Nef, and Vpr). We summarize evidence from human and animal studies, in vitro studies, and associated mechanisms. We further summarize evidence of synergy or lack thereof between commonly abused substances (cocaine, methamphetamine, alcohol, tobacco, opioids, and cannabinoids) and HIV- or viral protein-induced BBB injury and dysfunction. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Scalability study on [133La]LaCl3 production with a focus on potential clinical applications.
- Author
-
Brühlmann, Santiago Andrés, Walther, Martin, Blei, Magdalena Kerstin, Mamat, Constantin, Kopka, Klaus, Freudenberg, Robert, and Kreller, Martin
- Subjects
- *
CHEMICAL properties , *RADIOLABELING , *CLINICAL medicine , *RADIATION , *RADIOPHARMACEUTICALS - Abstract
Background: In recent years, targeted alpha therapy has gained importance in the clinics, and in particular, the alpha-emitter 225Ac plays a fundamental role in this clinical development. Nevertheless, depending on the chelating system no real diagnostic alternative has been established which shares similar chemical properties with this alpha-emitting radionuclide. In fact, the race to launch a diagnostic radionuclide to form a matched pair with 225Ac is still open, and 133La features attractive radiation properties to claim this place. However, in order to enable its translation into clinical use, upscaling of the production of this PET radionuclide is needed. Results: A study on optimal irradiation parameters, separation conditions and an exhaustive product characterization was carried out. In this framework, a proton irradiation of 2 h, 60 µA and 18.7 MeV produced 133La activities of up to 10.7 GBq at end of bombardment. In addition, the performance of four different chromatographic resins were tested and two optimized purification methods presented, taking approximately 20 min with a 133La recovery efficiencies of over 98%, decay corrected. High radionuclide purity and apparent molar activity was proved, of over 99.5% and 120 GBq/µmol, respectively, at end of purification. Furthermore, quantitative complexation of PSMA-617 and mcp-M-PSMA were obtained with molar activities up to 80 GBq/µmol. In addition, both 133La-radioconjugates offered high stability in serum, of over (98.5 ± 0.3)% and (99.20 ± 0.08)%, respectively, for up to 24 h. A first dosimetry estimation was also performed and it was calculated that an 133La application for imaging with between 350 and 750 MBq would only have an effective dose of 2.1–4.4 mSv, which is comparable to that of 18F and 68Ga based radiopharmaceuticals. Conclusions: In this article we present an overarching study on 133La production, from the radiation parameters optimization to a clinical dose estimation. Lanthanum-133 activities in the GBq range could be produced, formulated as [133La]LaCl3 with high quality regarding radiolabeling and radionuclide purity. We believe that increasing the 133La availability will further promote the development of radiopharmaceuticals based on macropa or other chelators suitable for 225Ac. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. People living with HIV co‐infected with the Kaposi Sarcoma‐associated Herpes Virus have a distinct HIV Tat profile and higher rates of antiretroviral virologic failure, more evident among those with Kaposi's sarcoma.
- Author
-
Suterio, Dalila G., Hunter, James R., Tenore, Simone B., Pimentel, Sidnei R., Galinskas, Juliana, Dias, Danilo A., Bellini, Débora C., Ferreira, Paulo A., and Diaz, Ricardo Sobhie
- Subjects
KAPOSI'S sarcoma ,GENETIC profile ,TAT protein ,HIV-positive persons ,ANTIRETROVIRAL agents - Abstract
Kaposi sarcoma (KS) is a neoplasm of vascular origin that promotes angiogenesis and the growth of endothelial cells triggered by the Kaposi Sarcoma‐associated Herpes Virus (KSHV). When associated with HIV, KSHV becomes more aggressive and rapidly evolves. The HIV‐1 TAT protein can be essential in developing AIDS‐associated KS by promoting angiogenesis and increasing KSHV replication. Therefore, we evaluated the genetic profile of the first exon of tat gene among groups of people living with HIV (PLHIV) with (case group, n = 36) or without KS, this later with (positive control group, n = 46) and without KSHV infection (negative control group, n = 24); all individuals under antiretroviral therapy. The genetic diversity, the DN/DS ratio, and the genetic entropy of the first exon of tat were higher in the case group, followed by the positive control group, which was higher than the negative control group. The number of tat codons under positive selection was seven in the case group, six in the positive control group, and one in the negative control group. The prevalence of HIV viral loads below the detection limit was equal in the case and positive control groups, which were lower than in the negative control group. The mean CD4+ T cell counts were higher in the negative control group, followed by the positive control group, and followed by the case group. These results emphasize the negative influence of KSHV in antiretroviral treatment, as well as the HIV‐specific TAT profile among PLHIV who developed KS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Scalability study on [133La]LaCl3 production with a focus on potential clinical applications
- Author
-
Santiago Andrés Brühlmann, Martin Walther, Magdalena Kerstin Blei, Constantin Mamat, Klaus Kopka, Robert Freudenberg, and Martin Kreller
- Subjects
TAT ,133La ,225Ac ,Macropa ,Targetry ,Dosimetry ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Abstract Background In recent years, targeted alpha therapy has gained importance in the clinics, and in particular, the alpha-emitter 225Ac plays a fundamental role in this clinical development. Nevertheless, depending on the chelating system no real diagnostic alternative has been established which shares similar chemical properties with this alpha-emitting radionuclide. In fact, the race to launch a diagnostic radionuclide to form a matched pair with 225Ac is still open, and 133La features attractive radiation properties to claim this place. However, in order to enable its translation into clinical use, upscaling of the production of this PET radionuclide is needed. Results A study on optimal irradiation parameters, separation conditions and an exhaustive product characterization was carried out. In this framework, a proton irradiation of 2 h, 60 µA and 18.7 MeV produced 133La activities of up to 10.7 GBq at end of bombardment. In addition, the performance of four different chromatographic resins were tested and two optimized purification methods presented, taking approximately 20 min with a 133La recovery efficiencies of over 98%, decay corrected. High radionuclide purity and apparent molar activity was proved, of over 99.5% and 120 GBq/µmol, respectively, at end of purification. Furthermore, quantitative complexation of PSMA-617 and mcp-M-PSMA were obtained with molar activities up to 80 GBq/µmol. In addition, both 133La-radioconjugates offered high stability in serum, of over (98.5 ± 0.3)% and (99.20 ± 0.08)%, respectively, for up to 24 h. A first dosimetry estimation was also performed and it was calculated that an 133La application for imaging with between 350 and 750 MBq would only have an effective dose of 2.1–4.4 mSv, which is comparable to that of 18F and 68Ga based radiopharmaceuticals. Conclusions In this article we present an overarching study on 133La production, from the radiation parameters optimization to a clinical dose estimation. Lanthanum-133 activities in the GBq range could be produced, formulated as [133La]LaCl3 with high quality regarding radiolabeling and radionuclide purity. We believe that increasing the 133La availability will further promote the development of radiopharmaceuticals based on macropa or other chelators suitable for 225Ac. Graphical abstract
- Published
- 2024
- Full Text
- View/download PDF
7. Smad2/3/4 complex could undergo liquid liquid phase separation and induce apoptosis through TAT in hepatocellular carcinoma
- Author
-
Jiong Li, Wendi Wang, Sang Li, Zhengkang Qiao, Haoyue Jiang, Xinyue Chang, Yaning Zhu, Hongpei Tan, Xiaoqian Ma, Yuqian Dong, Zhenhu He, Zhen Wang, Qin Liu, Shanhu Yao, Cejun Yang, Min Yang, Lu Cao, Juan Zhang, Wei Li, Wei Wang, Zhe Yang, and Pengfei Rong
- Subjects
Smad2/3/4 complex ,HCC ,LLPS ,TAT ,Caspase-9 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 ,Cytology ,QH573-671 - Abstract
Abstract Background Hepatocellular carcinoma (HCC) represents one of the most significant causes of mortality due to cancer-related deaths. It has been previously reported that the TGF-β signaling pathway may be associated with tumor progression. However, the relationship between TGF-β signaling pathway and HCC remains to be further elucidated. The objective of our research was to investigate the impact of TGF-β signaling pathway on HCC progression as well as the potential regulatory mechanism involved. Methods We conducted a series of bioinformatics analyses to screen and filter the most relevant hub genes associated with HCC. E. coli was utilized to express recombinant protein, and the Ni–NTA column was employed for purification of the target protein. Liquid liquid phase separation (LLPS) of protein in vitro, and fluorescent recovery after photobleaching (FRAP) were utilized to verify whether the target proteins had the ability to drive force LLPS. Western blot and quantitative real-time polymerase chain reaction (qPCR) were utilized to assess gene expression levels. Transcription factor binding sites of DNA were identified by chromatin immunoprecipitation (CHIP) qPCR. Flow cytometry was employed to examine cell apoptosis. Knockdown of target genes was achieved through shRNA. Cell Counting Kit-8 (CCK-8), colony formation assays, and nude mice tumor transplantation were utilized to test cell proliferation ability in vitro and in vivo. Results We found that Smad2/3/4 complex could regulate tyrosine aminotransferase (TAT) expression, and this regulation could relate to LLPS. CHIP qPCR results showed that the key targeted DNA binding site of Smad2/3/4 complex in TAT promoter region is −1032 to −1182. In addition. CCK-8, colony formation, and nude mice tumor transplantation assays showed that Smad2/3/4 complex could repress cell proliferation through TAT. Flow cytometry assay results showed that Smad2/3/4 complex could increase the apoptosis of hepatoma cells. Western blot results showed that Smad2/3/4 complex would active caspase-9 through TAT, which uncovered the mechanism of Smad2/3/4 complex inducing hepatoma cell apoptosis. Conclusion This study proved that Smad2/3/4 complex could undergo LLPS to active TAT transcription, then active caspase-9 to induce hepatoma cell apoptosis in inhibiting HCC progress. The research further elucidate the relationship between TGF-β signaling pathway and HCC, which contributes to discover the mechanism of HCC development.
- Published
- 2024
- Full Text
- View/download PDF
8. Caffeine upregulates SIRT3 expression to ameliorate astrocytes-mediated HIV-1 Tat neurotoxicity via suppression of EGR1 signaling pathway.
- Author
-
Gao, Lin, Sun, Weixi, Zhang, Lei, Liang, Caixia, and Zhang, Dongmei
- Subjects
- *
NEUROBEHAVIORAL disorders , *CENTRAL nervous system , *NEURODEGENERATION , *OXIDATIVE stress , *CELLULAR signal transduction - Abstract
Caffeine is one of the most popular consumed psychostimulants that mitigates several neurodegenerative diseases. Nevertheless, the roles and molecular mechanisms of caffeine in HIV-associated neurocognitive disorders (HAND) remain largely unclear. Transactivator of transcription (Tat) is a major contributor to the neuropathogenesis of HAND in the central nervous system. In the present study, we determined that caffeine (100 µM) treatment significantly ameliorated Tat-induced decreased astrocytic viability, oxidative stress, inflammatory response and excessive glutamate and ATP release, thereby protecting neurons from apoptosis. Subsequently, SIRT3 was demonstrated to display neuroprotective effects against Tat during caffeine treatment. In addition, Tat downregulated SIRT3 expression via activation of EGR1 signaling, which was reversed by caffeine treatment in astrocytes. Overexpression of EGR1 entirely abolished the neuroprotective effects of caffeine against Tat. Furthermore, counteracting Tat or caffeine-induced differential expression of SIRT3 abrogated the neuroprotection of caffeine against Tat-triggered astrocytic dysfunction and neuronal apoptosis. Taken together, our study establishes that caffeine ameliorates astrocytes-mediated Tat neurotoxicity by targeting EGR1/SIRT3 signaling pathway. Our findings highlight the beneficial effects of caffeine on Tat-induced astrocytic dysfunction and neuronal death and propose that caffeine might be a novel therapeutic drug for relief of HAND. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. 血清 FM、TAT、MIP-1α 与产后静脉血栓栓塞症的关系 及其预测价值研究.
- Author
-
张珊珊, 孟 侠, 王静依, 彭 燕, 陈国艳, and 杨智玲
- Abstract
To investigate the relationship between serum fibrin monomer (FM), thrombin-antithrombin complex (TAT), macrophage inflammatory protein-1α (MIP-1α) and postpartum venous thromboembolism (VTE) and its predictive value. Pregnant women with VTE after delivery in The Second Affiliated Hospital of Chengdu Medical College from December 2021 to December 2023 were included in VTE group (n=45), pregnant women without VTE after delivery in our hospital during the same period were included in non-VTE group (n=180) according to the 1:4 pairing method. Serum FM, TAT, MIP-1α and D-dimer (D-D) levels were detected by enzyme-linked immunosorbent assay (ELISA). The influencing factors of postpartum VTE were analyzed by multivariate Logistic regression analysis, and the predictive value of serum FM, TAT, MIP-1α and D-D levels for postpartum VTE were analyzed by receiver operating characteristic (ROC) curve. Compared with non-VTE group, the serum levels of FM, TAT, MIP-1α and D-D in VTE group were increased (P<0.05). Multivariate Logistic regression analysis showed that, increased age, uterine-incision delivery and increased FM, TAT, MIP-1α, and D-D were independent risk factors for postpartum VTE (P<0.05). ROC curve analysis showed that, the area under the curve of combined prediction of serum FM, TAT, MIP-1α and D-D levels for postpartum VTE was 0.911, which was greater than 0.748, 0.755, 0.722 and 0.592 predicted by serum FM, TAT, MIP-1α and D-D levels alone. The increase of serum FM, TAT and MIP-1α levels are independent risk factors for postpartum VTE, serum FM, TAT, MIP-1α combine with D-D has a high predictive value for postpartum VTE. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Milk‐derived extracellular vesicles functionalized with anti‐tumour necrosis factor‐α nanobody and anti‐microbial peptide alleviate ulcerative colitis in mice.
- Author
-
Jing, Renwei, Zhang, Leijie, Li, Ruibin, Yang, Zhongqiu, Song, Jun, Wang, Qian, Cao, Nan, Han, Gang, and Yin, HaiFang
- Subjects
- *
ULCERATIVE colitis , *EXTRACELLULAR vesicles , *PEPTIDES , *GREEN fluorescent protein , *ANTIMICROBIAL peptides , *MILK proteins , *CATHELICIDINS - Abstract
Ulcerative colitis (UC) manifests clinically with chronic intestinal inflammation and microflora dysbiosis. Although biologics can effectively control inflammation, efficient delivery to the colon and colon epithelial cells remains challenging. Milk‐derived extracellular vesicles (EV) show promise as an oral delivery tool, however, the ability to load biologics into EV presents challenges to therapeutic applications. Here, we demonstrate that fusing cell‐penetrating peptide (TAT) to green fluorescent protein (GFP) enabled biologics loading into EV and protected against degradation in the gastrointestinal environment in vitro and in vivo after oral delivery. Oral administration of EV loaded with anti‐tumour necrosis factor‐α (TNF‐α) nanobody (VHHm3F) (EVVHH) via TAT significantly reduced tissue TNF‐α levels and alleviated pathologies in mice with acute UC, compared to VHH alone. In mice with chronic UC, simultaneously introducing VHH and an antimicrobial peptide LL37 into EV (EVLV), then administering orally improved intestinal barrier, inflammation and microbiota balance, resulted in relief of UC‐induced depression and anxiety. Collectively, we demonstrated that oral delivery of EVLV effectively alleviated UC in mice and TAT efficiently loaded biologics into EV to confer protection from degradation in the gastrointestinal tract. This therapeutic strategy is promising for UC and is a simple and generalizable approach towards drug‐loaded orally‐administrable EV treatment for other diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Liposome nanoparticle conjugation and cell penetrating peptide sequences (CPPs) enhance the cellular delivery of the tau aggregation inhibitor RI‐AG03.
- Author
-
Reich, Niklas, Parkin, Edward, and Dawson, Neil
- Subjects
AMINO acid sequence ,LIPOSOMES ,NANOPARTICLES ,TAU proteins ,ALZHEIMER'S disease ,PEPTIDES - Abstract
Given the pathological role of Tau aggregation in Alzheimer's disease (AD), our laboratory previously developed the novel Tau aggregation inhibitor peptide, RI‐AG03. As Tau aggregates accumulate intracellularly, it is essential that the peptide can traverse the cell membrane. Here we examine the cellular uptake and intracellular trafficking of RI‐AG03, in both a free and liposome‐conjugated form. We also characterize the impact of adding the cell‐penetrating peptide (CPP) sequences, polyarginine (polyR) or transactivator of transcription (TAT), to RI‐AG03. Our data show that liposome conjugation of CPP containing RI‐AG03 peptides, with either the polyR or TAT sequence, increased cellular liposome association three‐fold. Inhibition of macropinocytosis modestly reduced the uptake of unconjugated and RI‐AG03‐polyR‐linked liposomes, while having no effect on RI‐AG03‐TAT‐conjugated liposome uptake. Further supporting macropinocytosis‐mediated internalization, a 'fair' co‐localisation of the free and liposome‐conjugated RI‐AG03‐polyR peptide with macropinosomes and lysosomes was observed. Interestingly, we also demonstrate that RI‐AG03‐polyR detaches from liposomes following cellular uptake, thereby largely evading organellar entrapment. Collectively, our data indicate that direct membrane penetration and macropinocytosis are key routes for the internalization of liposomes conjugated with CPP containing RI‐AG03. Our study also demonstrates that peptide‐liposomes are suitable nanocarriers for the cellular delivery of RI‐AG03, furthering their potential use in targeting Tau pathology in AD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Smad2/3/4 complex could undergo liquid liquid phase separation and induce apoptosis through TAT in hepatocellular carcinoma.
- Author
-
Li, Jiong, Wang, Wendi, Li, Sang, Qiao, Zhengkang, Jiang, Haoyue, Chang, Xinyue, Zhu, Yaning, Tan, Hongpei, Ma, Xiaoqian, Dong, Yuqian, He, Zhenhu, Wang, Zhen, Liu, Qin, Yao, Shanhu, Yang, Cejun, Yang, Min, Cao, Lu, Zhang, Juan, Li, Wei, and Wang, Wei
- Subjects
- *
COLONY-forming units assay , *PHASE separation , *APOPTOSIS , *ESCHERICHIA coli , *RECOMBINANT proteins , *GENE expression , *HEPATOCELLULAR carcinoma - Abstract
Background: Hepatocellular carcinoma (HCC) represents one of the most significant causes of mortality due to cancer-related deaths. It has been previously reported that the TGF-β signaling pathway may be associated with tumor progression. However, the relationship between TGF-β signaling pathway and HCC remains to be further elucidated. The objective of our research was to investigate the impact of TGF-β signaling pathway on HCC progression as well as the potential regulatory mechanism involved. Methods: We conducted a series of bioinformatics analyses to screen and filter the most relevant hub genes associated with HCC. E. coli was utilized to express recombinant protein, and the Ni–NTA column was employed for purification of the target protein. Liquid liquid phase separation (LLPS) of protein in vitro, and fluorescent recovery after photobleaching (FRAP) were utilized to verify whether the target proteins had the ability to drive force LLPS. Western blot and quantitative real-time polymerase chain reaction (qPCR) were utilized to assess gene expression levels. Transcription factor binding sites of DNA were identified by chromatin immunoprecipitation (CHIP) qPCR. Flow cytometry was employed to examine cell apoptosis. Knockdown of target genes was achieved through shRNA. Cell Counting Kit-8 (CCK-8), colony formation assays, and nude mice tumor transplantation were utilized to test cell proliferation ability in vitro and in vivo. Results: We found that Smad2/3/4 complex could regulate tyrosine aminotransferase (TAT) expression, and this regulation could relate to LLPS. CHIP qPCR results showed that the key targeted DNA binding site of Smad2/3/4 complex in TAT promoter region is −1032 to −1182. In addition. CCK-8, colony formation, and nude mice tumor transplantation assays showed that Smad2/3/4 complex could repress cell proliferation through TAT. Flow cytometry assay results showed that Smad2/3/4 complex could increase the apoptosis of hepatoma cells. Western blot results showed that Smad2/3/4 complex would active caspase-9 through TAT, which uncovered the mechanism of Smad2/3/4 complex inducing hepatoma cell apoptosis. Conclusion: This study proved that Smad2/3/4 complex could undergo LLPS to active TAT transcription, then active caspase-9 to induce hepatoma cell apoptosis in inhibiting HCC progress. The research further elucidate the relationship between TGF-β signaling pathway and HCC, which contributes to discover the mechanism of HCC development. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Indirecte methoden
- Author
-
Versteeg, Eric, Berghuis, Han, editor, Ingenhoven, Theo, editor, and van der Heijden, Paul, editor
- Published
- 2024
- Full Text
- View/download PDF
14. Human Immunodeficiency Virus
- Author
-
Paredes-Juarez, Genaro Alberto, Velázquez-Márquez, Noé, editor, Paredes-Juárez, Genaro Alberto, editor, and Vallejo-Ruiz, Verónica, editor
- Published
- 2024
- Full Text
- View/download PDF
15. Bacterial Protein Transport Pathways and Analogous Conserved Pathways in Eukaryotes
- Author
-
Kauffman, Philip, Kaushik, Sharbani, Kuhn, Andreas, Dalbey, Ross E., Schwartzbach, Steven D., editor, Kroth, Peter G., editor, and Oborník, Miroslav, editor
- Published
- 2024
- Full Text
- View/download PDF
16. The Effectiveness of Recent Policyholder-Friendly Laws at Addressing Complaints in India
- Author
-
Yadav, Uma Shankar, Sood, Kiran, Grima, Simon, Marano, Pierpaolo, Series Editor, Bataller Grau, Juan, Editorial Board Member, Chang, Johnny, Editorial Board Member, Chrissanthis, Christos S, Editorial Board Member, Cousy, Herman, Editorial Board Member, Grima, Simon, Editorial Board Member, Gurses, Ozlem, Editorial Board Member, Heiss, Helmut, Editorial Board Member, Hjalmarsson, Johanna, Editorial Board Member, Kochenburger, Peter, Editorial Board Member, Koezuka, Tadao, Editorial Board Member, Kullmann, Jérôme, Editorial Board Member, Kuschke, Birgit, Editorial Board Member, Kwon, W. Jean J., Editorial Board Member, Landini, Sara, Editorial Board Member, Lara Gonzáles, Rafael, Editorial Board Member, Lima Rego, Margarida, Editorial Board Member, Lin, JJ, Editorial Board Member, Luo, Can, Editorial Board Member, Malinowska, Katarzyna, Editorial Board Member, Martinez, Leo P., Editorial Board Member, McCoy, Patricia, Editorial Board Member, Meggit, Gary, Editorial Board Member, Merkin, Robert, Editorial Board Member, Millard, Daleen, Editorial Board Member, Munoz Paredes, Maria Luisa, Editorial Board Member, Nakaide, Satoshi, Editorial Board Member, Norio, Jaana, Editorial Board Member, Noussia, Kyriaki, Editorial Board Member, Núñez, Laura, Editorial Board Member, Perner, Stefan, Editorial Board Member, Ríos Ossa, Roberto, Editorial Board Member, Rokas, Ioannis, Editorial Board Member, Siri, Michele, Editorial Board Member, Van Schoubroeck, Caroline, Editorial Board Member, Veiga Copo, Abel, Editorial Board Member, Verheyen, Wouter, Editorial Board Member, Wandt, Manfred, Editorial Board Member, Wang, Hsin-Chun, Editorial Board Member, Yeşilova Aras, Ecehan, Editorial Board Member, and Zhu, Ling, Editorial Board Member
- Published
- 2024
- Full Text
- View/download PDF
17. The lysine methyltransferase SMYD5 amplifies HIV-1 transcription and is post-transcriptionally upregulated by Tat and USP11
- Author
-
Boehm, Daniela, Lam, Victor, Schnolzer, Martina, and Ott, Melanie
- Subjects
Biological Sciences ,HIV/AIDS ,Infectious Diseases ,Genetics ,Sexually Transmitted Infections ,Aetiology ,2.2 Factors relating to the physical environment ,Infection ,HIV-1 ,Lysine ,Methyltransferases ,RNA ,RNA ,Viral ,tat Gene Products ,Human Immunodeficiency Virus ,Transcription ,Genetic ,CP: Microbiology ,SMYD5 ,TAR RNA ,Tat ,USP11 ,latency ,Biochemistry and Cell Biology ,Medical Physiology ,Biological sciences - Abstract
A successful HIV-1 cure strategy may require enhancing HIV-1 latency to silence HIV-1 transcription. Modulators of gene expression show promise as latency-promoting agents in vitro and in vivo. Here, we identify Su(var)3-9, enhancer-of-zeste, and trithorax (SET) and myeloid, Nervy, and DEAF-1 (MYND) domain-containing protein 5 (SMYD5) as a host factor required for HIV-1 transcription. SMYD5 is expressed in CD4+ T cells and activates the HIV-1 promoter with or without the viral Tat protein, while knockdown of SMYD5 decreases HIV-1 transcription in cell lines and primary T cells. SMYD5 associates in vivo with the HIV-1 promoter and binds the HIV trans-activation response (TAR) element RNA and Tat. Tat is methylated by SMYD5 in vitro, and in cells expressing Tat, SMYD5 protein levels are increased. The latter requires expression of the Tat cofactor and ubiquitin-specific peptidase 11 (USP11). We propose that SMYD5 is a host activator of HIV-1 transcription stabilized by Tat and USP11 and, together with USP11, a possible target for latency-promoting therapy.
- Published
- 2023
18. Are Gamers Prone to eThrombosis during Long Gaming Sessions?
- Author
-
Krarup, Kasper B., Krarup, Henrik B., Mørk, Morten, Lundbye-Christensen, Søren, Handberg, Aase, Nguyen, Hien T. T., Pedersen, Inge S., and Kristensen, Søren R.
- Subjects
- *
THROMBIN , *VENOUS thrombosis , *VIRTUAL reality , *LOCAL area networks , *PROTHROMBIN , *PHYSICAL activity , *CALORIC content of foods - Abstract
During the last two decades, several cases of venous thrombosis (VTE) after a prolonged period at a computer have been described, denominated as "eThrombosis". Video gaming on a computer has become very popular and can be a social activity where several players gather to play against each other or in a virtual environment for several days ("LAN (i.e., Local Area Network) parties") where the participants are sedentary and consuming calorie-rich food items. The aim of this study was to investigate potential coagulation activation during a 42 h LAN party. Nine male gamers volunteered for the LAN party. Citrated blood was sampled before and every 6 h, and plasma was analyzed for thrombin generation, thrombin–antithrombin complexes (TAT), prothrombin fragment 1 + 2 (F1 + 2), and D-dimer. Thrombin generation increased slightly but not significantly during the LAN party, whereas the coagulation activation markers were unchanged. These results do not indicate that the coagulation system is activated significantly during 42 h of gaming with minimal physical activity. Although increased activity cannot be excluded, it does not directly indicate a risk of VTE in general. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Advancements in PSMA ligand radiolabeling for diagnosis and treatment of prostate cancer: a systematic review.
- Author
-
Yuanzhuo Yan, Huixian Zhuo, Tengfei Li, Jintao Zhang, Min Tan, and Yue Chen
- Subjects
PROSTATE cancer ,CANCER diagnosis ,RADIOLABELING ,POSITRON emission tomography ,THERAPEUTICS ,TREATMENT effectiveness - Abstract
Prostate cancer(PCa), a leading global health concern, profoundly impacts millions of men worldwide. Progressing through two stages, it initially develops within the prostate and subsequently extends to vital organs such as lymph nodes, bones, lungs, and the liver. In the early phases, castration therapy is often employed to mitigate androgen effects. However, when prostate cancer becomes resistant to this treatment, alternative strategies become imperative. As diagnostic and treatment methodologies for prostate cancer continually advance, radioligand therapy (RLT) has emerged as a promising avenue, yielding noteworthy outcomes. The fundamental principle of RLT involves delivering radionuclide drugs to cancerous lesions through specific carriers or technologies. Subsequently, these radionuclide drugs release radioactive energy, facilitating the destruction of cancer cell tissues. At present, the positron emission tomography (PET) targeting PSMA has been widely developed for the use of diagnosis and staging of PCa. Notably, FDA-approved prostate-specific membrane antigen (PSMA) targeting agents, such as
68 Ga-PSMA-11 and177 Lu-PSMA-617, represent significant milestones in enhancing diagnostic precision and therapeutic efficacy. This review emphasizes the current research status and outcomes of various radionuclide-labeled PSMA ligands. The objective is to provide valuable insights for the continued advancement of diagnostic and therapeutic approaches in the realm of prostate cancer. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
20. Bioinformatics Insights on Viral Gene Expression Transactivation: From HIV-1 to SARS-CoV-2.
- Author
-
Patarca, Roberto and Haseltine, William A.
- Subjects
- *
GENE expression , *VIRAL genes , *TAT protein , *SARS-CoV-2 , *HIV - Abstract
Viruses provide vital insights into gene expression control. Viral transactivators, with other viral and cellular proteins, regulate expression of self, other viruses, and host genes with profound effects on infected cells, underlying inflammation, control of immune responses, and pathogenesis. The multifunctional Tat proteins of lentiviruses (HIV-1, HIV-2, and SIV) transactivate gene expression by recruiting host proteins and binding to transacting responsive regions (TARs) in viral and host RNAs. SARS-CoV-2 nucleocapsid participates in early viral transcription, recruits similar cellular proteins, and shares intracellular, surface, and extracellular distribution with Tat. SARS-CoV-2 nucleocapsid interacting with the replication–transcription complex might, therefore, transactivate viral and cellular RNAs in the transcription and reactivation of self and other viruses, acute and chronic pathogenesis, immune evasion, and viral evolution. Here, we show, by using primary and secondary structural comparisons, that the leaders of SARS-CoV-2 and other coronaviruses contain TAR-like sequences in stem-loops 2 and 3. The coronaviral nucleocapsid C-terminal domains harbor a region of similarity to TAR-binding regions of lentiviral Tat proteins, and coronaviral nonstructural protein 12 has a cysteine-rich metal binding, dimerization domain, as do lentiviral Tat proteins. Although SARS-CoV-1 nucleocapsid transactivated gene expression in a replicon-based study, further experimental evidence for coronaviral transactivation and its possible implications is warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. HIV-1 Proviral Genome Engineering with CRISPR-Cas9 for Mechanistic Studies.
- Author
-
Hyder, Usman, Shukla, Ashutosh, Challa, Ashwini, and D'Orso, Iván
- Subjects
- *
HIV , *CRISPRS , *LIFE cycles (Biology) , *VIRAL proteins , *GENOME editing , *T cells - Abstract
HIV-1 latency remains a barrier to a functional cure because of the ability of virtually silent yet inducible proviruses within reservoir cells to transcriptionally reactivate upon cell stimulation. HIV-1 reactivation occurs through the sequential action of host transcription factors (TFs) during the "host phase" and the viral TF Tat during the "viral phase", which together facilitate the positive feedback loop required for exponential transcription, replication, and pathogenesis. The sequential action of these TFs poses a challenge to precisely delineate the contributions of the host and viral phases of the transcriptional program to guide future mechanistic and therapeutic studies. To address this limitation, we devised a genome engineering approach to mutate tat and create a genetically matched pair of Jurkat T cell clones harboring HIV-1 at the same integration site with and without Tat expression. By comparing the transcriptional profile of both clones, the transition point between the host and viral phases was defined, providing a system that enables the temporal mechanistic interrogation of HIV-1 transcription prior to and after Tat synthesis. Importantly, this CRISPR method is broadly applicable to knockout individual viral proteins or genomic regulatory elements to delineate their contributions to various aspects of the viral life cycle and ultimately may facilitate therapeutic approaches in our race towards achieving a functional cure. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Chronic HIV‐1 Tat action induces HLA‐DR downregulation in B cells: A mechanism for lymphoma immune escape in people living with HIV.
- Author
-
Shmakova, Anna, Hugot, Coline, Kozhevnikova, Yana, Schwager, Anna, Tsimailo, Ivan, Gérard, Laurence, Boutboul, David, Oksenhendler, Eric, Szewczyk‐Roszczenko, Olga, Roszczenko, Piotr, Buzun, Kamila, Sheval, Eugene V., Germini, Diego, and Vassetzky, Yegor
- Abstract
Despite the success of combination antiretroviral therapy, people living with human immunodeficiency virus (HIV) still have an increased risk of Epstein−Barr virus (EBV)‐associated B cell malignancies. In the HIV setting, B cell physiology is altered by coexistence with HIV‐infected cells and the chronic action of secreted viral proteins, for example, HIV‐1 Tat that, once released, efficiently penetrates noninfected cells. We modeled the chronic action of HIV‐1 Tat on B cells by ectopically expressing Tat or TatC22G mutant in two lymphoblastoid B cell lines. The RNA‐sequencing analysis revealed that Tat deregulated the expression of hundreds of genes in B cells, including the downregulation of a subset of major histocompatibility complex (MHC) class II‐related genes. Tat‐induced downregulation of HLA‐DRB1 and HLA‐DRB5 genes led to a decrease in HLA‐DR surface expression; this effect was reproduced by coculturing B cells with Tat‐expressing T cells. Chronic Tat presence decreased the NF‐ᴋB pathway activity in B cells; this downregulated NF‐ᴋB‐dependent transcriptional targets, including MHC class II genes. Notably, HLA‐DRB1 and surface HLA‐DR expression was also decreased in B cells from people with HIV. Tat‐induced HLA‐DR downregulation in B cells impaired EBV‐specific CD4+ T cell response, which contributed to the escape from immune surveillance and could eventually promote B cell lymphomagenesis in people with HIV. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Milk‐derived extracellular vesicles functionalized with anti‐tumour necrosis factor‐α nanobody and anti‐microbial peptide alleviate ulcerative colitis in mice
- Author
-
Renwei Jing, Leijie Zhang, Ruibin Li, Zhongqiu Yang, Jun Song, Qian Wang, Nan Cao, Gang Han, and HaiFang Yin
- Subjects
ulcerative colitis ,TNF‐α nanobody ,TAT ,milk‐derived EV ,LL37 ,Cytology ,QH573-671 - Abstract
Abstract Ulcerative colitis (UC) manifests clinically with chronic intestinal inflammation and microflora dysbiosis. Although biologics can effectively control inflammation, efficient delivery to the colon and colon epithelial cells remains challenging. Milk‐derived extracellular vesicles (EV) show promise as an oral delivery tool, however, the ability to load biologics into EV presents challenges to therapeutic applications. Here, we demonstrate that fusing cell‐penetrating peptide (TAT) to green fluorescent protein (GFP) enabled biologics loading into EV and protected against degradation in the gastrointestinal environment in vitro and in vivo after oral delivery. Oral administration of EV loaded with anti‐tumour necrosis factor‐α (TNF‐α) nanobody (VHHm3F) (EVVHH) via TAT significantly reduced tissue TNF‐α levels and alleviated pathologies in mice with acute UC, compared to VHH alone. In mice with chronic UC, simultaneously introducing VHH and an antimicrobial peptide LL37 into EV (EVLV), then administering orally improved intestinal barrier, inflammation and microbiota balance, resulted in relief of UC‐induced depression and anxiety. Collectively, we demonstrated that oral delivery of EVLV effectively alleviated UC in mice and TAT efficiently loaded biologics into EV to confer protection from degradation in the gastrointestinal tract. This therapeutic strategy is promising for UC and is a simple and generalizable approach towards drug‐loaded orally‐administrable EV treatment for other diseases.
- Published
- 2024
- Full Text
- View/download PDF
24. Biological effects and mechanism of β-amyloid aggregation inhibition by penetrable recombinant human HspB5-ACD structural domain protein
- Author
-
Chang Liu, Xuying Ding, Meijun Zhao, Chen Chen, Xiaojun Zhang, Risheng Zhao, Yutong Chen, and Yining Xie
- Subjects
AD ,HspB5 ,ACD structural domain ,TAT ,Aβ1–42 ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Alzheimer's disease (AD) is a global medical challenge. Studies have shown that neurotoxicity caused by pathological aggregation of β-amyloid (Aβ) is an important factor leading to AD. Therefore, inhibiting the pathological aggregation of Aβ is the key to treating AD. The recombinant human HspB5-ACD structural domain protein (AHspB5) prepared by our group in the previous period has been shown to have anti-amyloid aggregation effects, but its inability to penetrate biological membranes has limited its development. In this study, we prepared a recombinant fusion protein (T-AHspB5) of TAT and AHspB5. In vitro experiments showed that T-AHspB5 inhibited the formation of Aβ1–42 protofibrils and had the ability to penetrate the blood-brain barrier; in cellular experiments, T-AHspB5 prevented Aβ1–42-induced oxidative stress damage, apoptosis, and inflammatory responses in neuronal cells, and its mechanism of action was related to microglia activation and mitochondria-dependent apoptotic pathway. In animal experiments, T-AHspB5 improved memory and cognitive dysfunction and inhibited pathological changes of AD in APP/PS1 mice. In conclusion, this paper is expected to reveal the intervention mechanism and biological effect of T-AHspB5 on pathological aggregation of Aβ1–42, provide a new pathway for the treatment of AD, and lay the foundation for the future development and application of T-AHspB5.
- Published
- 2024
- Full Text
- View/download PDF
25. Integrative Lighting Aimed at Patients with Psychiatric and Neurological Disorders
- Author
-
Xinxi Zeng, Thierry Silvio Claude Soreze, Martin Ballegaard, and Paul Michael Petersen
- Subjects
CIE S026 ,circadian ,MEDI ,integrative lighting ,MLIT ,TAT ,Medicine - Abstract
The purpose of this paper is to investigate the impact of circadian lighting-induced melatonin suppression on patients with psychiatric and neurological disorders in hospital wards by using an ad-hoc metrology framework and the subsequent metrics formalized by the CIE in 2018. A measurement scheme was conducted in hospital ward rooms in the Department of Neurology, Zealand University Hospital, at Roskilde in Denmark, to evaluate the photometric and colorimetric characteristics of the lighting system, as well as its influence on the circadian rhythm of the occupants. The measurement scheme included point measurements and data logging, using a spectrophotometer mounted on a tripod with adjustable height to assess the newly installed circadian lighting system. The measured spectra were uploaded to the Luox platform to calculate illuminance, CCT, MEDI, etc., in accordance with the CIE S026 standard. Furthermore, the MLIT based on MEDI data logging results was calculated. In addition to CIE S026, we have investigated the usefulness of melatonin suppression models for the assessment of circadian performance regarding measured light. From the results, the lighting conditions in the patient room for both minimal and abundant daylight access were evaluated and compared; we found that access to daylight is essential for both illumination and circadian entrainment. It can be concluded that the measurement scheme, together with the use of the Luox platform and Canva template, is suitable for the accurate and satisfactory measurement of integrative lighting that aligns with CIE requirements and recommendations.
- Published
- 2023
- Full Text
- View/download PDF
26. Tuberculosis in geriatric patients: a cross-sectional study from tertiary care hospital in Maharashtra
- Author
-
Pooja Shah, Sae Pol, Vaishali Gaikwad, Jyoti Jyoti, and Rajesh Karyakarte
- Subjects
cbnaaat ,m. tuberculosis ,geriatric ,tat ,Medicine - Abstract
Background- By the year 2031, an anticipated 194 million Indian population will be aged 60 years or above. They are more prone to various infections due to lowered immunity and Tuberculosis (TB) is one of them. The use of various diagnostic methods for TB needs to be investigated in the geriatric population. Material and methods: A cross-sectional study was conducted from 1st January 2022 to 31st December 2022. All TB patients of 60 years and above were enrolled. Their sputum samples were subjected to CBNAAT and positive samples were tested by LPA for detection of isoniazid resistance and resistance to second-line drugs. Results: In our study, most positive cases were from the age group of 60-65 years (50.82%). Infected males were 65.57% and females were 34.43%. M. CBNAAT detected tuberculosis in 18.43%. 90.16% were rifampicin sensitive, and resistant were 8.20%. By LPA, isoniazid monoresistant was seen in 4.92%, rifampicin monoresistant in 1.64%. Conclusion: As per our study, geriatric patients in the age group of 60-65 years were mainly positive for tuberculosis. This age group though immunocompromised but still active can spread the infection in the community. So, this age group should be closely observed in the mission of NTEP.
- Published
- 2023
- Full Text
- View/download PDF
27. Structural and Functional Dysregulation of the Brain Endothelium in HIV Infection and Substance Abuse
- Author
-
Narendran Annadurai and Georgette D. Kanmogne
- Subjects
blood–brain barrier ,HIV-associated neurocognitive disorder ,endothelial cells ,viral proteins ,gp120 ,Tat ,Cytology ,QH573-671 - Abstract
Blood–brain barrier (BBB) injury and dysfunction following infection with the human immunodeficiency virus (HIV) enables viral entry into the brain, infection of resident brain cells, neuronal injury and subsequent neurodegeneration leading to HIV-associated neurocognitive disorders (HAND). Although combination antiretroviral therapy has significantly reduced the incidence and prevalence of acquired immunodeficiency syndrome and increased the life expectancy of people living with HIV, the prevalence of HAND remains high. With aging of people living with HIV associated with increased comorbidities, the prevalence of HIV-related central nervous system (CNS) complications is expected to remain high. Considering the principal role of the brain endothelium in HIV infection of the CNS and HAND, the purpose of this manuscript is to review the current literature on the pathobiology of the brain endothelium structural and functional dysregulation in HIV infection, including in the presence of HIV-1 and viral proteins (gp120, Tat, Nef, and Vpr). We summarize evidence from human and animal studies, in vitro studies, and associated mechanisms. We further summarize evidence of synergy or lack thereof between commonly abused substances (cocaine, methamphetamine, alcohol, tobacco, opioids, and cannabinoids) and HIV- or viral protein-induced BBB injury and dysfunction.
- Published
- 2024
- Full Text
- View/download PDF
28. Suppression of HIV-TAT and cocaine-induced neurotoxicity and inflammation by cell penetrable itaconate esters
- Author
-
Cui, B. Celia, Aksenova, Marina, Sikirzhytskaya, Aliaksandra, Odhiambo, Diana, Korunova, Elizaveta, Sikirzhytski, Vitali, Ji, Hao, Altomare, Diego, Broude, Eugenia, Frizzell, Norma, Booze, Rosemarie, Wyatt, Michael D., and Shtutman, Michael
- Published
- 2024
- Full Text
- View/download PDF
29. Transcriptional regulation of the HIV-1 inhibitory factor human mannose receptor 1 by the myeloid-specific transcription factor PU.1.
- Author
-
Mallorson, Rosa, Miyagi, Eri, Kao, Sandra, Sayaka Sukegawa, Hideki Saito, Fabryova, Helena, Ruggieri, Luciana Morellatto, Mediouni, Sonia, Valente, Susana T., and Strebel, Klaus
- Subjects
- *
GENETIC transcription regulation , *TRANSCRIPTION factors , *MANNOSE , *HIV , *GENE expression - Abstract
HIV-1 infection of human macrophages leads to the downmodulation of human mannose receptor 1 (hMRC1), a cell-surface glycoprotein that is involved in the host innate immune response. We previously reported that downmodulation of hMRC1 involves the transactivator of transcription (Tat)-dependent transcriptional silencing of the hMRC1 promoter. However, the inhibitory effect of Tat on hMRC1 transcription was indirect and involved inhibition of the transcriptional activator PU.1, which normally upregulates hMRC1 expression in macrophages and other myeloid cells. We cloned a 284-bp fragment of the hMRC1 promoter, and within it, we identified four PU.1 box elements. We assessed the relative contribution of each of the four PU.1 boxes to PU.1-dependent transcriptional regulation and, surprisingly, found that only one of the four PU.1 boxes [PU.1(b)] was critically required for PU.1-mediated upregulation of luciferase expression. Transfer of this PU.1 box to a heterologous promoter conferred PU.1 responsiveness to an otherwise PU.1 insensitive promoter. Electrophoretic mobility shift assays identified this PU.1 box as a direct binding site for PU.1 both in the context of the hMRC1 promoter and the heterologous promoter. Furthermore, mutational analysis of the PU.1 protein identified the C-terminal DNA-binding domain in PU.1 as the region responsible for interaction with the PU.1 box. Recombinant HIV-1 Tat protein did not bind to the hMRC1 promoter element but efficiently interfered with the binding of PU.1 protein to the hMRC1 promoter. Thus, Tat is likely to inhibit the formation of active PU.1 transcription complexes, presumably by binding to and depleting common transcriptional cofactors. IMPORTANCE HIV-1 infection of cells results in the modulation of cellular gene expression by virus-encoded proteins in a manner that benefits the virus. We reported that HIV-1 transactivator of transcription (Tat) dysregulates the expression of the human mannose receptor 1 (hMRC1). hMRC1 is involved in the innate immune response of macrophages to foreign pathogens. Tat does not act directly on the hMRC1 promoter but instead inhibits PU.1, a cellular transcription factor regulating hMRC1 gene expression. Here, we characterize the PU.1-dependent regulation of hMRC1 expression. We ident ified four potential PU.1 binding sites in the hMRC1 promoter region but found that only one, PU.1(b), functioned as a true binding site for PU.1. Transfer of the PU.1(b) box to a heterologous promoter did not activate this promoter per se but rendered it responsive to PU.1. Our results support the view that PU.1 acts as a transcriptional co-factor whose activity can be regulated by HIV-1 Tat. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. A Context-Aware Internet of Things (IoT) founded Approach to Scheming an Operative Priority-Based Scheduling Algorithms.
- Author
-
Roy, Vandana
- Subjects
INTERNET of things ,ALGORITHMS ,SCHEDULING - Abstract
In recent years, smart computing has emerged as a promising and rapidly expanding field of technology. It senses the environment in real time and gives powerful analytics to perform intelligent decisions. Creating a scheduling algorithm based on priorities in order to decrease IoT process latency was the primary emphasis of the study challenge. The constraints of existing scheduling algorithms were investigated in order to build a scheduling algorithm that is based on priorities. We provide a context-based priority scheduling method to get around these restrictions. In order to determine which steps of the IoT process were crucial, we developed context attributes. Once the criticality has been identified, the proposed scheduling technique is used to schedule the IoT processes. The outcomes of the algorithms were confirmed using a variety of evaluation indicators. As demonstrated by the experimental results, the suggested scheduling algorithms outperformed the state-of-the-art techniques. Smart ATM uses a Case Study technique to analyse the algorithm. We identified the sensors that are part of the ATM and the settings in which they are relevant. We determined the priority value for each sensor. The processes are subsequently categorized according to their priority values. Then, a priority-based FCFS scheduling algorithm is used, and its performance is assessed using metrics like Average TAT, Cost, Energy, and the High critical process TAT ratio. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Integrative Lighting Aimed at Patients with Psychiatric and Neurological Disorders.
- Author
-
Zeng, Xinxi, Soreze, Thierry Silvio Claude, Ballegaard, Martin, and Petersen, Paul Michael
- Subjects
- *
PEOPLE with mental illness , *DAYLIGHT , *HOSPITAL wards , *DATA logging , *CIRCADIAN rhythms , *LIGHTING - Abstract
The purpose of this paper is to investigate the impact of circadian lighting-induced melatonin suppression on patients with psychiatric and neurological disorders in hospital wards by using an ad-hoc metrology framework and the subsequent metrics formalized by the CIE in 2018. A measurement scheme was conducted in hospital ward rooms in the Department of Neurology, Zealand University Hospital, at Roskilde in Denmark, to evaluate the photometric and colorimetric characteristics of the lighting system, as well as its influence on the circadian rhythm of the occupants. The measurement scheme included point measurements and data logging, using a spectrophotometer mounted on a tripod with adjustable height to assess the newly installed circadian lighting system. The measured spectra were uploaded to the Luox platform to calculate illuminance, CCT, MEDI, etc., in accordance with the CIE S026 standard. Furthermore, the MLIT based on MEDI data logging results was calculated. In addition to CIE S026, we have investigated the usefulness of melatonin suppression models for the assessment of circadian performance regarding measured light. From the results, the lighting conditions in the patient room for both minimal and abundant daylight access were evaluated and compared; we found that access to daylight is essential for both illumination and circadian entrainment. It can be concluded that the measurement scheme, together with the use of the Luox platform and Canva template, is suitable for the accurate and satisfactory measurement of integrative lighting that aligns with CIE requirements and recommendations. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
32. The Role of p53 in HIV Infection.
- Author
-
Yaseen, Mahmoud Mohammad, Abuharfeil, Nizar Mohammad, and Darmani, Homa
- Abstract
Purpose of Review: This review aims to elucidate the multifaceted role of the tumor suppressor protein p53 in the context of HIV infection. We explore how p53, a pivotal regulator of cellular processes, interacts with various facets of the HIV life cycle. Understanding these interactions could provide valuable insights into potential therapeutic interventions and the broader implications of p53 in viral infections. Recent Findings: Recent research has unveiled a complex interplay between p53 and HIV. Several reports have highlighted the involvement of p53 in restricting the replication of HIV within both immune and nonimmune cells. Various mechanisms have been suggested to unveil how p53 enforces this restriction on HIV replication. However, HIV has developed strategies to manipulate p53, benefiting its replication and evading host defenses. Summary: In summary, p53 plays a multifaceted role in HIV infection, impacting viral replication and disease progression. Recent findings underscore the importance of understanding the intricate interactions between p53 and HIV for the development of innovative therapeutic approaches. Manipulating p53 pathways may offer potential avenues to suppress viral replication and ameliorate immune dysfunction, ultimately contributing to the management of HIV/AIDS. Further research is warranted to fully exploit the therapeutic potential of p53 in the context of HIV infection. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
33. Mathematical modelling of HIV-1 transcription inhibition: a comparative study between optimal control and impulsive approach.
- Author
-
Mondal, Srijita, Murmu, Tanushree, Chakravarty, Koyel, Sarkar, Ashis Kumar, and Sasmal, Sourav Kumar
- Subjects
RNA polymerase II ,IMPULSIVE differential equations ,HIV ,T helper cells ,NONLINEAR differential equations ,RNA polymerases ,DOUBLE-stranded RNA - Abstract
Through the utilization of a proactive approach, interaction with human immunodeficiency virus type I (HIV-1) is facilitated, enabling the sequential stages of its fusion mechanism to be navigated successfully. As a result, the efficient infiltration of a target C D 4 + T helper cell within the host organism by the virus is achieved. The onset of the virus's replication cycle is initiated through this infiltration. As a retrovirus, the orchestration of the conversion of its single-stranded viral RNA genome into a more stable double-stranded DNA structure by HIV-1 is observed. Integration of this newly formed DNA with the host cell's genetic material occurs. This pivotal transformation of the integrated pro-viral DNA into fully functional messenger RNA (mRNA) is facilitated by the host enzyme RNA polymerase II (Pol II). The central focus of the present ongoing research involves the construction of a meticulous mathematical framework consisting of a system of nonlinear differential equations. The investigation of the impact of a Tat inhibitor on the suppression of the transcriptional activity of HIV-1 is the aim of this inquiry. The perspective of an optimal control problem is assumed for this investigation. Furthermore, the assessment of the efficacy of the Tat inhibitor as a potential therapeutic intervention for HIV-1 infection is undertaken. Integration of a one-dimensional impulsive differential equation model, which determines a mathematically derived maximum concentration of the elongating complex ( P 2 ), is employed for this assessment. The crucial aspect of this investigation is the consideration of the optimal timing between successive dosages. A comparative analysis is conducted to evaluate the distinct effects of continuous dosing versus impulse dosing of the Tat inhibitor. Numerical analysis is employed to contrast the outcomes of these dosing strategies. The present findings highlight that impulsive dosing demonstrates superior effectiveness compared to continuous dosing in the inhibition of HIV-1 transcription. Ultimately, the model's parameter sensitivities are visualized through graphical representations. These visualizations serve to enhance the understanding of the underlying physiological and biochemical processes within this intricate system. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
34. Genotypic and Phenotypic Characterization of Replication-Competent HIV-2 Isolated from Controllers and Progressors.
- Author
-
Lungu, Cynthia, Overmars, Ronald J., Grundeken, Esmée, Boers, Patrick H. M., van der Ende, Marchina E., Mesplède, Thibault, and Gruters, Rob A.
- Subjects
- *
GENOTYPES , *LONG-term non-progressors , *TAT protein , *PHENOTYPES , *DISEASE progression - Abstract
Although some individuals with HIV-2 develop severe immunodeficiency and AIDS-related complications, most may never progress to AIDS. Replication-competent HIV-2 isolated from asymptomatic long-term non-progressors (controllers) have lower replication rates than viruses from individuals who progress to AIDS (progressors). To investigate potential retroviral factors that correlate with disease progression in HIV-2, we sequenced the near full-length genomes of replication-competent viruses previously outgrown from controllers and progressors and used phylogeny to seek genotypic correlates of disease progression. We validated the integrity of all open reading frames and used cell-based assays to study the retroviral transcriptional activity of the long terminal repeats (LTRs) and Tat proteins of HIV-2 from controllers and progressors. Overall, we did not identify genotypic defects that may contribute to HIV-2 non-progression. Tat-induced, LTR-mediated transcription was comparable between viruses from controllers and progressors. Our results were obtained from a small number of participants and should be interpreted accordingly. Overall, they suggest that progression may be determined before or during integration of HIV-2. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
35. Features of Tat Protein in HIV-1 Sub-Subtype A6 Variants Circulating in the Moscow Region, Russia.
- Author
-
Kuznetsova, Anna, Kim, Kristina, Tumanov, Alexander, Munchak, Iana, Antonova, Anastasiia, Lebedev, Aleksey, Ozhmegova, Ekaterina, Orlova-Morozova, Elena, Drobyshevskaya, Elena, Pronin, Alexander, Prilipov, Aleksey, and Kazennova, Elena
- Subjects
- *
TAT protein , *HIV infections , *HIV-positive persons , *HIV , *VIRAL variation , *PROTEOMICS - Abstract
Tat, the trans-activator of transcription, is a multifunctional HIV-1 protein that can induce chronic inflammation and the development of somatic diseases in HIV-infected patients. Natural polymorphisms in Tat can impact the propagation of the inflammatory signal. Currently, Tat is considered an object for creating new therapeutic agents. Therefore, the identification of Tat protein features in various HIV-1 variants is a relevant task. The purpose of the study was to characterize the genetic variations of Tat-A6 in virus variants circulating in the Moscow Region. The authors analyzed 252 clinical samples from people living with HIV (PLWH) with different stages of HIV infection. Nested PCR for two fragments (tat1, tat2) with subsequent sequencing, subtyping, and statistical analysis was conducted. The authors received 252 sequences for tat1 and 189 for tat2. HIV-1 sub-subtype A6 was identified in 250 samples. The received results indicated the features of Tat1-A6 in variants of viruses circulating in the Moscow Region. In PLWH with different stages of HIV infection, C31S in Tat1-A6 was detected with different occurrence rates. It was demonstrated that Tat2-A6, instead of a functional significant 78RGD80 motif, had a 78QRD80 motif. Herewith, G79R in Tat2-A6 was defined as characteristic amino acid substitution for sub-subtype A6. Tat2-A6 in variants of viruses circulating in the Moscow Region demonstrated high conservatism. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
36. Dual vs. triple antithrombotic treatment after percutaneous coronary intervention in patients with non-valvular atrial fibrillation: a meta-analysis on current evidence.
- Author
-
ACCONCIA, M. C., CARETTA, Q., CHIAROTTI, F., TANZILLI, G., TORROMEO, C., PANNARALE, G., and GAUDIO, C.
- Abstract
OBJECTIVE: Combination and duration of antithrombotic therapy in order to prevent both stent thrombosis and thromboembolic complications after coronary artery stenting (PCI) in non-valvular atrial fibrillation (AF) is still debated. This uncertainty can be attributed mainly to the fact that the reference trials were open-label and not adequately powered in order to reach a definitive conclusion on ischemic endpoints (i.e., stent thrombosis). On these grounds, data from real-life studies could support evidence on dual antithrombotic treatment (DAT) safety (bleeding risk) and efficacy (stent thrombosis prevention). The aim of the meta-analysis is to investigate in both randomized controlled trials (RCTs) and observational studies (Obs) the risks and/or benefits related to DAT vs. triple antithrombotic treatment (TAT) regimens in patients affected by AF undergoing PCI. MATERIALS AND METHODS: RCTs and Obs were retrieved through PubMed database. The risk ratio with 95% confidence interval was used to compare the primary and the safety endpoints. RESULTS: Meta-analysis demonstrated no significant differences between DAT vs. TAT for mortality. However, a two-fold higher mortality rate was registered in Obs than in RCTs. The Obs did not confirm the expected significant reduction in bleeding risk shown by the RCTs; however, the bleeding rates in Obs were more than three-fold those of RCTs. In Obs, a significant greater risk for stent thrombosis was observed in DAT than in TAT. CONCLUSIONS: The safety and efficacy outcomes observed in RCTs are unrealistic with respect to the current clinical practice. So, more evidence is needed to have more exhaustive guidelines based on RCTs with homogeneous designs and protocols that should mimic real-life population and practice. [ABSTRACT FROM AUTHOR]
- Published
- 2023
37. Therapeutic Intervention Using a Smad7-Based Tat Protein to Treat Radiation-Induced Oral Mucositis.
- Author
-
Boss, Mary-Keara, Ke, Yao, Bian, Li, Harrison, Lauren, Lee, Ber-In, Prebble, Amber, Martin, Tiffany, Trageser, Erin, Hall, Spencer, Wang, Donna, Wang, Suyan, Chow, Lyndah, Holwerda, Barry, Raben, David, Regan, Daniel, Karam, Sana, Dow, Steven, Young, Christian, and Wang, Xiao-Jing
- Subjects
Animals ,Dogs ,Gene Products ,tat ,Mice ,Mucositis ,Radiation Injuries ,Smad7 Protein ,Stomatitis ,Transforming Growth Factor beta - Abstract
PURPOSE: Recent studies reported therapeutic effects of Smad7 on oral mucositis in mice without compromising radiation therapy-induced cancer cell killing in neighboring oral cancer. This study aims to assess whether a Smad7-based biologic can treat oral mucositis in a clinically relevant setting by establishing an oral mucositis model in dogs and analyzing molecular targets. METHODS AND MATERIALS: We created a truncated human Smad7 protein fused with the cell-penetrating Tat tag (Tat-PYC-Smad7). We used intensity modulated radiation therapy to induce oral mucositis in dogs and applied Tat-PYC-Smad7 to the oral mucosa in dose-finding studies after intensity modulated radiation therapy. Clinical outcomes were evaluated. Molecular targets were analyzed in biopsies and serum samples. RESULTS: Tat-PYC-Smad7 treatment significantly shortened the duration of grade 3 oral mucositis based on double-blinded Veterinary Radiation Therapy Oncology Group scores and histopathology evaluations. Topically applied Tat-PYC-Smad7 primarily penetrated epithelial cells and was undetectable in serum. NanoString nCounter Canine IO Panel identified that, compared to the vehicle samples, top molecular changes in Tat-PYC-Smad7 treated samples include reductions in inflammation and cell death and increases in cell growth and DNA repair. Consistently, immunostaining shows that Tat-PYC-Smad7 reduced DNA damage and neutrophil infiltration with attenuated TGF-β and NFκB signaling. Furthermore, IL-1β and TNF-α were lower in Tat-PYC-Smad7 treated mucosa and serum samples compared to those in vehicle controls. CONCLUSIONS: Topical Tat-PYC-Smad7 application demonstrated therapeutic effects on oral mucositis induced by intensity modulated radiation therapy in dogs. The local effects of Tat-PYC-Smad7 targeted molecules involved in oral mucositis pathogenesis as well as reduced systemic inflammatory cytokines.
- Published
- 2022
38. The Role of Laboratory in Urgency/Emergency
- Author
-
Ciaccio, Marcello, Agnello, Luisa, Carraro, Paolo, and Ciaccio, Marcello, editor
- Published
- 2023
- Full Text
- View/download PDF
39. Suppression of epithelial to mesenchymal transition markers in mouse lens by a Smad7-based recombinant protein.
- Author
-
Hupy, Matthew, Pedler, Michelle, Shieh, Biehuoy, Wang, Dongyan, Wang, Xiao-Jing, and Petrash, J
- Subjects
Aldose reductase ,Cataract ,Epithelial-to-mesenchymal transition ,Lens ,Smad ,Actins ,Animals ,Capsule Opacification ,Cataract ,Cell-Penetrating Peptides ,Epithelial Cells ,Epithelial-Mesenchymal Transition ,Gene Products ,tat ,Lens ,Crystalline ,Mice ,Transgenic ,Protein Domains ,Recombinant Proteins ,Smad7 Protein - Abstract
Cataracts, a clouding of the eye lens, are a leading cause of visual impairment and are responsible for one of the most commonly performed surgical procedures worldwide. Although generally safe and effective, cataract surgery can lead to a secondary lens abnormality due to transition of lens epithelial cells to a mesenchymal phenotype (EMT) and opacification of the posterior lens capsular bag. Occurring in up to 40% of cataract cases over time, posterior capsule opacification (PCO) introduces additional treatment costs and reduced quality of life for patients. Studies have shown that PCO pathogenesis is driven in part by TGF-β, signaling through the action of the family of Smad coactivators to effect changes in gene transcription. In the present study, we evaluated the ability of Smad-7, a well characterized inhibitor of TGF-β -mediated Smad signaling, to suppress the EMT response in lens epithelial cells associated with PCO pathogenesis. Treatment of lens epithelial cells with a cell-permeable form of Smad7 variant resulted in suppressed expression of EMT markers such as alpha smooth muscle actin and fibronectin. A single application of cell-permeable Smad7 variant in the capsular bag of a mouse cataract surgery model resulted in suppression of gene transcripts encoding alpha smooth muscle actin and fibronectin. These results point to Smad7 as a promising biotherapeutic agent for prevention or substantial reduction in the incidence of PCO following cataract surgery.
- Published
- 2021
40. Spontaneous intramuscular hemorrhage in cancer-associated dermatomyositis: a case and literature review
- Author
-
Rui Xing, Fenfen Xiang, Lingli Dong, and Guifen Shen
- Subjects
Dermatomyositis ,Spontaneous intramuscular hemorrhage ,Hematoma ,TAT ,PIC ,t-PAIC ,Diseases of the musculoskeletal system ,RC925-935 - Abstract
Abstract Background Spontaneous intramuscular hemorrhage (SIH) is a rare but life-threatening complication of dermatomyositis (DM). The pathogenetic mechanism and management of intramuscular hematoma in these patients remains unclear. Here we discuss a case of recurrent hemorrhage in a patient with cancer-associated DM, and review the relevant literature for timely diagnosis and treatment. Case presentation A 53-year-old male patient presented with rashes, muscle weakness, and dysphagia and was diagnosed with DM. During treatment, he developed SIH of the arm and right psoas major muscle successively. MRI showed extensive edema of the right shoulder girdle muscle and muscle groups of the upper arm. During the second SIH, a CT scan showed new-onset hematoma formation in the right psoas major muscle. The detection of D-dimer, thrombin-antithrombin III complex (TAT), plasmin-α2-plasmininhibitor complex (PIC) and tissue plasminogen activator-inhibitor complex (t-PAIC) indicated predominant hyperfibrinolysis over thrombosis. Blood transfusion and supportive treatment were immediately performed, and the hematoma did not expand. However, his abdominal distension was not relieved after active treatment. Further electronic gastroscopy discovered gastric sinus ulcers, and histopathology of the biopsy confirmed signet-ring cell carcinoma. Conclusions Although patients with cancer-associated DM have an increased risk of thrombosis, prophylactic anticoagulation therapy needs deliberate consideration. It is important to monitor the coagulation parameters dynamically during anticoagulation therapy. Especially when the level of D-dimer is high, and it is uncertain whether the patient is in a state of thrombosis or hyperfibrinolysis, the detection of TAT, PIC, t-PAIC can help to determine whether to initiate anticoagulation therapy.
- Published
- 2023
- Full Text
- View/download PDF
41. Scalability study on [133La]LaCl3 production with a focus on potential clinical applications
- Author
-
Brühlmann, Santiago Andrés, Walther, Martin, Blei, Magdalena Kerstin, Mamat, Constantin, Kopka, Klaus, Freudenberg, Robert, and Kreller, Martin
- Published
- 2024
- Full Text
- View/download PDF
42. Molecular fragment characteristics and distribution of tangle associated TDP-43 (TATs) and other TDP-43 lesions in Alzheimer’s disease
- Author
-
Keith Anthony Josephs, Shunsuke Koga, Nirubol Tosakulwong, Stephen D. Weigand, Nha Trang Thu Pham, Matt Baker, Jennifer L. Whitwell, Rosa Rademakers, Leonard Petrucelli, and Dennis W. Dickson
- Subjects
TAR DNA binding protein 43 ,TMEM106b ,Cluster analysis ,TAT ,Hippocampal sclerosis ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
TAR DNA binding protein 43 (TDP-43) pathology is a defining feature of frontotemporal lobar degeneration (FTLD). In FTLD-TDP there is a moderate-to-high burden of morphologically distinctive TDP-43 immunoreactive inclusions distributed throughout the brain. In Alzheimer’s disease (AD), similar TDP-43 immunoreactive inclusions are observed. In AD, however, there is a unique phenomenon of neurofibrillary tangle-associated TDP-43 (TATs) whereby TDP-43 intermingles with neurofibrillary tangles. Little is known about the characteristics and distribution of TATs, or how burden and distribution of TATs compares to burden and distribution of other FTLD-TDP-like lesions observed in AD. Here we characterize molecular fragment characteristics, burden and distribution of TATs and assess how these features compare to features of other TDP-43 lesions. We performed TDP-43 immunohistochemistry with anti-phosphorylated, C- and N-terminal TDP-43 antibodies in 20 high-probability AD cases and semi-quantitative burden of seven inclusion types within five brain regions (entorhinal cortex, subiculum, CA1 and dentate gyrus of hippocampus, occipitotemporal cortex). Hierarchical cluster analysis was used to analyze the dataset that consisted of 75 different combinations of neuropathological features. TATs were nonspherical with heterogeneous staining patterns and present in all regions except hippocampal dentate. All three antibodies detected TATs although N-terminal antibody sensitivity was low. Three clusters were identified: Cluster-1 had mild-moderate TATs, moderate-frequent neuronal cytoplasmic inclusions, dystrophic neurites, neuronal intranuclear inclusions and fine neurites, and perivascular and granular inclusions identified only with the N-terminal antibody throughout the brain; Cluster-2 had scant TATs in limbic regions and Cluster-3 mild-moderate TATs and mild-moderate neuronal cytoplasmic inclusions and dystrophic neurites throughout the brain and moderate fine neurites. Only 17% of cluster 1 cases had the TMEM106b GG (protective) haplotype and 83% had hippocampal sclerosis. Both features differed across clusters (p=0.03 & p=0.01). TATs have molecular characteristics, distribution and burden, and genetic and pathologic associations like FTLD-TDP lesions.
- Published
- 2023
- Full Text
- View/download PDF
43. Neurological, Behavioral, and Pathophysiological Characterization of the Co-Occurrence of Substance Use and HIV: A Narrative Review.
- Author
-
Vines, Leah, Sotelo, Diana, Giddens, Natasha, Manza, Peter, Volkow, Nora D., and Wang, Gene-Jack
- Subjects
- *
SUBSTANCE abuse , *HIV infection transmission , *HIV-1 glycoprotein 120 , *TAT protein , *HIV - Abstract
Combined antiretroviral therapy (cART) has greatly reduced the severity of HIV-associated neurocognitive disorders in people living with HIV (PLWH); however, PLWH are more likely than the general population to use drugs and suffer from substance use disorders (SUDs) and to exhibit risky behaviors that promote HIV transmission and other infections. Dopamine-boosting psychostimulants such as cocaine and methamphetamine are some of the most widely used substances among PLWH. Chronic use of these substances disrupts brain function, structure, and cognition. PLWH with SUD have poor health outcomes driven by complex interactions between biological, neurocognitive, and social factors. Here we review the effects of comorbid HIV and psychostimulant use disorders by discussing the distinct and common effects of HIV and chronic cocaine and methamphetamine use on behavioral and neurological impairments using evidence from rodent models of HIV-associated neurocognitive impairments (Tat or gp120 protein expression) and clinical studies. We also provide a biopsychosocial perspective by discussing behavioral impairment in differentially impacted social groups and proposing interventions at both patient and population levels. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
44. Trimester-specific reference intervals of hemostasis biomarkers for healthy pregnancy.
- Author
-
Xiao, Haijun, Yu, Weijian, Li, Lihua, Yin, Xiaoqin, Zhai, Qingna, Hu, Die, Zhang, Xiufa, and Wang, Feng
- Subjects
- *
HEMOSTASIS , *PREGNANCY , *CHEMILUMINESCENCE immunoassay , *IMMUNOASSAY , *PREGNANT women , *ENZYME-linked immunosorbent assay - Abstract
Physiological changes in hemostasis during pregnancy have been reported by several authors. This study aimed at establishing reference intervals for the hemostasis biomarkers thrombin-antithrombin complex (TAT), α2-plasmininhibitor-plasmin complex (PIC), thrombomodulin (TM) and tissue plasminogen activator-inhibitor complex (tPAI-C), in healthy pregnancies. After excluding outliers, a total of 496 healthy pregnant women (128 first-trimester, 142 second-trimester, 107 third-trimester and 119 pre-labor) and 103 healthy nonpregnant women were enrolled from Shenzhen Bao'an Women's and Children's Hospital. Hemostasis biomarkers, TAT, PIC, TM and tPAI-C, were measured by using a quantitative chemiluminescence enzyme immunoassay performed on HISCL automated analysers. The median and reference intervals (the 2.5th and 97.5th percentiles) were calculated to establish trimester-specific reference intervals for healthy pregnant women. The reference intervals for TAT, PIC, TM and tPAI-C in the first trimester were 0.7–7.6 1 µg/L, 0.2–0.9 mg/L, 2.8–11.0 TU/ml, and 1.2–6.5 1 µg/L, respectively. The reference intervals in the second trimester were 1.7–12.0 1 µg/L, 0.2–1.0 mg/L, 3.7–11.6 TU/ml, and 2.8–8.8 1 µg/L, respectively. The reference intervals in the third trimester were 2.7–16.1 1 µg/L, 0.1–1.4 mg/L, 2.9–12.9 TU/ml, and 1.9–8.0 1 µg/L, respectively. At pre–labor, the reference intervals were 4.8–32.9 1 µg/L, 0.2–1.9 mg/L, 4.2–12.6 TU/ml, and 2.8–15.4 1 µg/L, respectively. Gestational reference intervals for TAT, PIC, TM and tPAI-C in healthy pregnancies are provided, but only for TAT with increasing concentrations throughout pregnancy, the reference intervals for non-pregnant were not applicable. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
45. HIV-1 subtype B Tat enhances NOTCH3 signaling in astrocytes to mediate oxidative stress, inflammatory response, and neuronal apoptosis.
- Author
-
Gao, Lin, Sun, Weixi, Zhang, Dongmei, Shang, Yanxing, Li, Li, Tao, Wenhua, Zhang, Lei, and Liu, Hongbin
- Subjects
- *
OXIDATIVE stress , *INFLAMMATION , *ASTROCYTES , *NEUROBEHAVIORAL disorders , *HIV , *NOTCH genes - Abstract
NOTCH receptors are relevant to multiple neurodegenerative diseases. However, the roles and mechanisms of NOTCH receptors in HIV-associated neurocognitive disorder (HAND) remain largely unclear. Transactivator of transcription (Tat) induces oxidative stress and inflammatory response in astrocytes, thereby leading to neuronal apoptosis in the central nervous system. We determined that NOTCH3 expression was upregulated during subtype B or C Tat expression in HEB astroglial cells. Moreover, bioinformatics analysis of the Gene Expression Omnibus (GEO) dataset revealed that NOTCH3 mRNA expression in the frontal cortex tissues of HIV encephalitis patients was higher than that of HIV control patients. Of note, subtype B Tat, rather than subtype C Tat, interacted with the extracellular domain of the NOTCH3 receptor, thus activating NOTCH3 signaling. Downregulation of NOTCH3 attenuated subtype B Tat-induced oxidative stress and reactive oxygen species generation. In addition, we demonstrated that NOTCH3 signaling facilitated subtype B Tat-activated NF-κB signaling pathway, thereby mediating pro-inflammatory cytokines IL-6 and TNF-α production. Furthermore, downregulation of NOTCH3 in HEB astroglial cells protected SH-SY5Y neuronal cells from astrocyte-mediated subtype B Tat neurotoxicity. Taken together, our study clarifies the potential role of NOTCH3 in subtype B Tat-induced oxidative stress and inflammatory response in astrocytes, which could be a novel therapeutic target for the relief of HAND. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
46. Predictive role of culture-based MIC testing vs. genotyping for carbapenem-resistant Enterobacterales in a non-universal screening, highly resourced setting.
- Author
-
Alnimr, Amani M.
- Subjects
- *
MEROPENEM , *KRUSKAL-Wallis Test , *PREDICTIVE tests , *ACADEMIC medical centers , *MICROBIAL genetics , *CROSS-sectional method , *ONE-way analysis of variance , *CARBAPENEM-resistant bacteria , *MEDICAL screening , *ENTEROBACTERIACEAE diseases , *RETROSPECTIVE studies , *MOLECULAR biology , *COMPARATIVE studies , *DESCRIPTIVE statistics , *FACTOR analysis , *CARBAPENEMS , *DATA analysis software , *SENSITIVITY & specificity (Statistics) , *MICROBIAL sensitivity tests , *GENETIC profile , *PHENOTYPES , *IMIPENEM - Abstract
A lack of evidence of accuracy for various testing modalities for carbapenem-resistant Enterobacterales (CRE) reduces the efficiency of screening and delays the isolation of carriers. This study examined the performance of phenotypic detection of CRE in comparison to molecular testing. A cross-sectional study was conducted in an academic medical institution in Saudi Arabia on CRE-screened patients during a 36-month period (April 1, 2019, through March 31, 2022). Cases were followed up for their susceptibility status by the phenotypic gradient method and genotypes. Of 3,116 samples tested, 359 carbapenemase genes were detected in 297 strains (9.5%) belonging to 292 patients. Oxacilliniase-48 (OXA-48) was the most frequently detected genotype (n=190, 64%), followed by a combined New Delhi metallo-B-lactamase (NDM)/OXA-48 genotype (n=77, 25.9%). Variable missed isolation days were encountered for various genotypes (0-18.5 days), with an excellent clinical utility index obtained for screening the OXA-48 genotype phenotypically. The data provided some insights into the predictive role and shortcomings of the e-test alone in CRE screening. While it provided a reasonable approach in a CRE population dominated by OXA-48 genotypes, it was more likely to miss the NDM-incurred carbapenemase. Thus, local epidemiology in an institution must be considered when designing a local screening protocol in addition to consideration of cost and turnaround time. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
47. Transactivator of Transcription (Tat)-Induced Neuroinflammation as a Key Pathway in Neuronal Dysfunction: A Scoping Review
- Author
-
Muvenda, Tshengedzeni, Williams, Aurelia A., and Williams, Monray Edward
- Published
- 2024
- Full Text
- View/download PDF
48. Electrochromic shift supports the membrane destabilization model of Tat-mediated transport and shows ion leakage during Sec transport
- Author
-
Asher, Anthony H and Theg, Steven M
- Subjects
Biochemistry and Cell Biology ,Biological Sciences ,Arginine ,Cell Membrane ,Cell-Penetrating Peptides ,Gene Products ,tat ,Ion Channel Gating ,Ions ,Protein Binding ,Protein Transport ,SEC Translocation Channels ,electrochromic shift ,twin arginine translocon ,Sec ,protein translocation ,toroidal pore - Abstract
The mechanism and pore architecture of the Tat complex during transport of folded substrates remain a mystery, partly due to rapid dissociation after translocation. In contrast, the proteinaceous SecY pore is a persistent structure that needs only to undergo conformational shifts between "closed" and "opened" states when translocating unfolded substrate chains. Where the proteinaceous pore model describes the SecY pore well, the toroidal pore model better accounts for the high-energy barrier that must be overcome when transporting a folded substrate through the hydrophobic bilayer in Tat transport. Membrane conductance behavior can, in principle, be used to distinguish between toroidal and proteinaceous pores, as illustrated in the examination of many antimicrobial peptides as well as mitochondrial Bax and Bid. Here, we measure the electrochromic shift (ECS) decay as a proxy for conductance in isolated thylakoids, both during protein transport and with constitutively assembled translocons. We find that membranes with the constitutively assembled Tat complex and those undergoing Tat transport display conductance characteristics similar to those of resting membranes. Membranes undergoing Sec transport and those with the substrate-engaged SecY pore result in significantly more rapid electric field decay. The responsiveness of the ECS signal in membranes with active SecY recalls the steep relationship between applied voltage and conductance in a proteinaceous pore, while the nonaccelerated electric field decay with both Tat transport and the constitutive Tat complex under the same electric field is consistent with the behavior of a toroidal pore.
- Published
- 2021
49. HIV-1C and HIV-1B Tat protein polymorphism in Southern Brazil
- Author
-
de Almeida, Sérgio Monteiro, Rotta, Indianara, Vidal, Luine Rosele Renaud, dos Santos, Jucelia Stadinicki, Nath, Avindra, Johnson, Kory, Letendre, Scott, and Ellis, Ronald J
- Subjects
Medical Microbiology ,Biomedical and Clinical Sciences ,HIV/AIDS ,Genetics ,Infection ,Adult ,Brazil ,Cross-Sectional Studies ,Female ,HIV-1 ,Humans ,Male ,Middle Aged ,Polymorphism ,Single Nucleotide ,tat Gene Products ,Human Immunodeficiency Virus ,Subtype C ,Tat ,Dicysteine ,Neuropathogenesis ,Polymorphism ,H. I. V. Neurobehavioral Research Center (HNRC) Group ,Clinical Sciences ,Neurosciences ,Virology ,Clinical sciences ,Medical microbiology - Abstract
The transactivator of transcription (Tat) is a key HIV regulatory protein. We aimed to identify the frequency of key polymorphisms in HIV-1C compared with HIV-1B Tat protein, chiefly in the cysteine-, arginine-, and glutamine-rich domains and identify novel point mutations in HIV-1B and C sequences from Southern Brazil. This study was the first to investigate the genetic diversity and point mutations within HIV-1 Tat C in a Brazilian cohort. This was an observational, cross-sectional study, which included sequences of HIV-1B (n = 20) and HIV-1C (n = 21) from Southern Brazil. Additionally, 344 HIV-1C sequences were obtained from the Los Alamos database: 29 from Brazil and 315 from Africa, Asia, and Europe. The frequency of C31S substitution on HIV-1 Tat C in Brazil was 82% vs. 10% in the HIV-1B group (p
- Published
- 2021
50. Oncogenic Effects of HIV-1 Proteins, Mechanisms Behind.
- Author
-
Isaguliants, Maria, Bayurova, Ekaterina, Avdoshina, Darya, Kondrashova, Alla, Chiodi, Francesca, and Palefsky, Joel M
- Subjects
Nef ,Tat ,carcinogenicity ,epithelial cells ,gp120 ,human immunodeficiency virus type 1 ,matrix protein p17 ,oxidative stress ,reactive oxygen species ,reverse transcriptase ,Oncology and Carcinogenesis - Abstract
People living with human immunodeficiency virus (HIV-1) are at increased risk of developing cancer, such as Kaposi sarcoma (KS), non-Hodgkin lymphoma (NHL), cervical cancer, and other cancers associated with chronic viral infections. Traditionally, this is linked to HIV-1-induced immune suppression with depletion of CD4+ T-helper cells, exhaustion of lymphopoiesis and lymphocyte dysfunction. However, the long-term successful implementation of antiretroviral therapy (ART) with an early start did not preclude the oncological complications, implying that HIV-1 and its antigens are directly involved in carcinogenesis and may exert their effects on the background of restored immune system even when present at extremely low levels. Experimental data indicate that HIV-1 virions and single viral antigens can enter a wide variety of cells, including epithelial. This review is focused on the effects of five viral proteins: envelope protein gp120, accessory protein negative factor Nef, matrix protein p17, transactivator of transcription Tat and reverse transcriptase RT. Gp120, Nef, p17, Tat, and RT cause oxidative stress, can be released from HIV-1-infected cells and are oncogenic. All five are in a position to affect "innocent" bystander cells, specifically, to cause the propagation of (pre)existing malignant and malignant transformation of normal epithelial cells, giving grounds to the direct carcinogenic effects of HIV-1.
- Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.